Novo Nordisk Strikes $2.1B Deal with Omeros to License Rare Disease Drug
October 16, 2025
3:00 PM
Novo Nordisk Strikes $2.1B Deal with Omeros to License Rare Disease Drug
Lilly’s Oral GLP-1 Pill Cuts Blood Sugar More Than Standard Drugs in Late-Stage Trials
Scientists Convert Donor Kidney’s Blood Type Before Transplant — A Breakthrough
Eating Kiwis Daily Can Relieve Constipation, Says New UK Medical Guidance
WHO and EU Launch €8M Pact to Digitize Health Systems in Sub-Saharan Africa
WHO Warns: Neurological Disorders Kill 11 Million Annually, With Few Policies in Place
“Markets Rally as Trump Eases Trade Tensions, AI Stocks Lead Rebound”
RBL Bank Stocks Soar as Emirates NBD Poised to Take Major Stake
Latest News
More From Next Click News
Explore Next Click News Categories
